We showed that DPP4 might regulate DHCR24-mediated cholesterol biosynthesis to promote methotrexate resistance in GTN cells, which may provide novel insights into the molecular mechanisms of drug resistance in GTN. Here, DPP4 is linked to gestational trophoblastic neoplasm.